Bartrum Thomas 4
4 · Privia Health Group, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Bartrum Thomas
EVP, General Counsel
Transactions
- Sale
Common Stock, $0.01 par value per share
2023-09-05$25.77/sh−15,000$386,550→ 106,114 total - Exercise/Conversion
Stock Option (Right to Purchase)
2023-09-05−3,333→ 21,667 totalExercise: $2.00Exp: 2035-09-07→ Common Stock (3,333 underlying) - Exercise/Conversion
Common Stock, $0.01 par value per share
2023-09-05$2.00/sh+15,000$30,000→ 121,114 total - Exercise/Conversion
Stock Option (Right to Purchase)
2023-09-05−4,287→ 17,149 totalExercise: $2.00Exp: 2034-12-03→ Common Stock (4,287 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2023-09-05−7,380→ 73,404 totalExercise: $2.00Exp: 2033-08-27→ Common Stock (7,380 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.54 to $25.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]All stock options are fully vested and exercisable.
- [F4]Prior to the transactions reported in this Form 4, 22,916 of the stock options were fully vested and exercisable. 2,084 of the stock options vest on September 8, 2023.